425: Strive & Semler Scientific Merger Update

Strive, Inc. posted a communication regarding its proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statements and associated risks.

Summary

• Strive, Inc. communicated about its proposed business combination with Semler Scientific, Inc.
• The communication was posted on X.com by Matthew Cole, CEO of Strive, on September 26, 2025.
• It includes a cautionary statement regarding forward-looking statements related to the proposed transaction.
• Strive intends to file a Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus.
• The Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders for approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when available.
• Strive, Semler Scientific, and certain directors/executive officers may be deemed participants in the solicitation of proxies.
• The communication is not an offer to sell or a solicitation of an offer to buy securities or a solicitation of any vote.

Sentiment

Score: 5

Explanation: The filing is primarily procedural and risk-focused regarding a proposed merger. It highlights potential benefits but heavily emphasizes numerous uncertainties and risks, leading to a neutral sentiment.

Positives

• The proposed transaction is expected to yield strategic benefits and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are expected from the proposed transaction.

Negatives

• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from customers or changes to business or employee relationships due to the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Risks

• Occurrence of any event, change, or circumstances that could give rise to the right of either company to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• Outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock.
• Potential adverse reactions of customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company.
• Unknown or unpredictable factors could also harm results.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed transaction, including cost savings and successful integration. However, these are subject to significant risks and uncertainties, including the timing and successful completion of the merger, integration challenges, and market conditions.

Management Comments

• Matthew Cole, CEO of Strive, Inc., posted a communication on X.com regarding the proposed business combination with Semler Scientific, Inc.

Industry Context

This filing is a standard procedural update for a proposed merger, common in industries undergoing consolidation or strategic shifts. The mention of "Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets" suggests a company potentially integrating digital asset holdings into its corporate strategy, which is a notable trend for some companies, particularly in the tech or financial sectors, though Semler Scientific is typically known for medical devices.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a risk.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is set forth in its definitive proxy statement for its 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Potential adverse reactions of Strive's or Semler Scientific's customers.
• Changes to business or employee relationships.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Recommendation

This filing is a procedural update regarding a proposed merger, heavily focused on cautionary statements and risks. While a merger can be positive, the document itself provides no new financial performance data or definitive positive catalysts, instead highlighting numerous uncertainties, potential delays, and integration challenges. An investor should hold and await further definitive information, particularly the S-4 filing, before making a more informed decision.

Keywords

Strive, Semler Scientific, merger, acquisition, business combination, SEC filing, Form 425, forward-looking statements, risk factors, corporate governance, Bitcoin treasury, digital assets